Complementary and Alternative Medicine for Diabetes by Wen-Chin Yang et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 831068, 3 pages
http://dx.doi.org/10.1155/2013/831068
Editorial
Complementary and Alternative Medicine for Diabetes
Wen-Chin Yang,1 Srinivas Nammi,2 Per Bendix Jeppesen,3 and William C. S. Cho4
1 Agricultural Biotechnology Research Center, Academia Sinica, Taipei 11501, Taiwan
2 School of Science and Health, University of Western Sydney, NSW 2751, Australia
3 Department of Endocrinology and Metabolism, Aarhus Sygehus THG, Aarhus University Hospital, Tage-Hansens Gade 2,
8000 Aarhus C, Denmark
4Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong
Correspondence should be addressed to Wen-Chin Yang; wcyang@gate.sinica.edu.tw
Received 5 August 2013; Accepted 5 August 2013
Copyright © 2013 Wen-Chin Yang et al.This is an open access article distributed under the Creative CommonsAttribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Although diabetes was identified by a Greek physician,
Aretaeus of Cappadocia, about 2,000 years ago, this old dis-
ease remains incurable. Diabetes is characterized by insulin
deficiency, insulin resistance, and aberrant glucose, protein,
and lipid metabolism. Genetic and environmental factors are
the primary causes of diabetes. It is estimated that about
300 million people globally are afflicted with this disease.
However, current oral antidiabetic agents using orthodox
medicine have unmet efficacy and undesirable side effects in
patients, leading to the development of microvascular and
macrovascular complications. Research and development of
new remedies for diabetes are, therefore, in great demand.
It is estimated that complementary and alternative
medicine (CAM) is used by 80% of the world population
for primary health care. Therefore CAM, including herbal
medicines, acupuncture, moxibustion, and other therapies,
represents an important area of exploration for diabetes
therapy. In this special issue, we aimed to gather together
updated information reflecting the considerable progress in
basic and clinical research into CAM for diabetes and its
complications.
The papers in this special issue cover a wide range of
topics, including in vitro studies, preclinical studies, and
clinical trials on CAM for diabetes and related diseases.
One in vitro study by S.-C. Chang and W.-C. V. Yang
titled “Hyperglycemia induces altered expressions of angio-
genesis associated molecules in the trophoblast” describes the
expression of perlecan and angiogenesis-related cytokines
and growth factors in trophoblasts, one type of placenta
cells. High glucose affected the expression level of cell-
bound perlecan, angiogenesis-associated cytokines, and the
matrix degradation on the cells, implying that hyperglycemia
influences vessel formation during placentation. A. Nachar et
al. (“The action of antidiabetic plants of the Canadian James
Bay Cree traditional pharmacopeia on key enzymes of hepatic
glucose homeostasis”) report the antidiabetic action of seven
Canadian plants as evidenced by glucose-6-phosphatase and
glycogen synthase, two key enzymes, respectively, involved
in gluconeogenesis and glycogenesis in hepatocytes. Among
them, Abies balsamifera and Picea glauca decreased glucose-
6-phosphatase activity. This decrease involved the Akt and
AMPK pathways. In contrast, Larix laricina and A. balsam-
ifera increased glycogen synthase activity. Preclinical studies
were used to study the action and mechanism of CAM
in rodents. Diabetes arises from a defect in 𝛽 cell func-
tions and insulin resistance. A small flavone-type molecule,
swertisin, found in Enicostemma littorale was tested for
its ability to promote the generation of pancreatic islets.
N. Dadheech et al. (“A small molecule swertisin from Eni-
costemma littorale differentiates NIH3T3 cells into islet-like
clusters and restores normoglycemia upon transplantation in
diabetic Balb/c mice”) showed that swertisin could promote
the differentiation of NIH3T3 cells into pancreatic islet-like
cell mass, which restored hypoglycemic status to normal.
Another study by C. L.-T Chang et al. (“Antidiabetic effect
and mode of action of cytopiloyne”) reported that a small
molecule, cytopiloyne, isolated from Bidens pilosa, improved
type 2 diabetes (T2DM) in db/db mice via its modulation of
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𝛽-cell functions (insulin production and 𝛽-cell preservation)
involving the calcium/DAG/PKC𝛼 cascade. J. Wang and
colleagues (“Improvement of liquid fructose-induced adipose
tissue insulin resistance by ginger treatment in rats is associated
with suppression of adipose macrophage-related proinflam-
matory cytokines”) show that treatment with ginger extract
reduced fructose-induced insulin resistance in rats by sup-
pression of adipose inflammatory cytokines (TNF-𝛼, IL-6,
MPC-1, CCR-2, etc.) and increased phosphorylation of IRS-
2. K. K. Tan and K. H. Kim. (“Alternanthera sessilis red ethyl
acetate fraction exhibits antidiabetic potential on obese type 2
diabetic rats”) report that, despite their inability to identify
active compounds, they observed that ethyl acetate fraction of
Alternanthera sessilis ameliorated T2D via increased insulin
content and decreased insulin resistance. Aside from blood
glucose, this fraction reduced blood triglyceride and free fatty
acids. S. H. Kim and coworkers (“Citrus junos Tanaka peel
extract exerts antidiabetic effects via AMPK and PPAR-𝛾 both
in vitro and in vivo in mice fed a high-fat diet”) indicate that
the ethanol extract of the peel of Citrus junos in vitro stim-
ulates glucose uptake in C2C12 myotube cells. This extract
also augmented activity of PPAR-𝛾 and AMPK in C2C12
cells. Consistent with the in vitro data, the extract diminished
insulin resistance as well as body weight and adipokines
and elevated AMPK phosphorylation in high-fat diet- (HFD-
) induced mice. N. Hu et al. (“Anti-diabetic activities of
Jiaotaiwan in db/db mice by augmentation of AMPK protein
activity and upregulation of GLUT4 expression”) demonstrate
the antidiabetic action of a traditional Chinese medicine
(TCM), Jiaotaiwan, as shown by reduction of blood glucose
level and enhancement of islet protection, hepatic AMPK
activity, and expression level of glucose transporter 4 in
skeletal muscle and white fat. H.-Y. Huang and colleagues
(“Supplementation of Lactobacillus plantarum K68 and fruit-
vegetable ferment along with high fat-fructose diet attenuates
metabolic syndrome in rats with insulin resistance”) report that
a mixture of fruit/vegetable ferment and one of its bacteria,
Lactobacillus plantarum K68, reduced hyperglycemia, hyper-
insulinemia, and hyperlipidemia as well as proinflammatory
cytokines (TNF-𝛼, IL-6, IL-1𝛽, etc.) in HFD-induced rats.
This reduction was associated with a decrease in insulin
resistance. P. V. Rao and coworkers (“Rhinacanthus nasutus
ameliorates cytosolic and mitochondrial enzyme levels in
streptozotocin-induced diabetic rats”) showed that glycolytic
enzymes such as glucose-6-phosphate dehydrogenase, suc-
cinate dehydrogenase, glutamate dehydrogenase, and lac-
tate dehydrogenase were upregulated in diabetic mice. In
contrast, the methanol extract of R. nasutus reduced those
enzymes, implying that this extract exerts antidiabetic action
via reduction of metabolic enzymes. In addition, two articles
delineate the impact of herbal medicine and compounds on
diabetic complications in animals (“Proanthocyanidin atten-
uation of oxidative stress and NF-𝜅B protects apolipoprotein E-
deficient mice against diabetic nephropathy” and “An aqueous
extract of Radix Astragali, Angelica sinensis, and Panax
notoginseng is effective in preventing diabetic retinopathy”).
One study by D. Gao and colleagues (“An aqueous extract of
Radix Astragali, Angelica sinensis, and Panax notoginseng is
effective in preventing diabetic retinopathy”) reports that Dang
Gui Bu Xue Tang, a TCM composed of A. membranaceus,
A. sinensis, and P. notoginseng, reduced diabetic retinopa-
thy in diabetic Goto-Kakizaki rats and/or streptozotocin-
(STZ-) induced rats. This reduction was associated with
retinal downregulation of proinflammatory cytokines and
the reversal of glucose-induced inhibition of endothelial cell
migration/proliferation in vitro. Another study shows that
treatment with the polyphenolic compounds proanthocyani-
dins reduced nephropathy in STZ-treated apolipoprotein E-
deficient mice (“Proanthocyanidin attenuation of oxidative
stress and NF-𝜅B protects apolipoprotein E-deficient mice
against diabetic nephropathy”). This reduction is relevant to
its attenuation of oxidative stress and NF-𝜅B activation.
In human clinical studies, X. Tu et al. (“Fructus mume
formula in the treatment of type 2 diabetes mellitus: a ran-
domized controlled pilot trial”) demonstrate that 12-week
treatment with a monofactorial formula, F. mume, reduced
blood glucose in 41 patients of T2DM. X. Li and colleagues
(“The rs1142345 in TPMT affects the therapeutic effect of
traditional hypoglycemic herbs in prediabetes”) concluded that
a single nucleotide polymorphism (rs1142345) in thiopurine
𝑆-methyltransferase could affect the therapeutic outcome of
the patients with T2DM receiving the TCM, Tianqi Jiang
Tang. C. X. Huang et al. (“Prescription pattern of Chinese
herbal products for diabetes mellitus in Taiwan: a population-
based study”) present the use and likely mechanisms of
action of multifactorial formulae such as Liu-Wei-Di-Huang-
Wan and its derivatives. Their antidiabetic mechanisms
are multifaceted and include increase in insulin secretion,
insulin sensitivity, peripheral glucose uptake, diminution of
intestinal glucose absorption, hepatic glucose, production
and insulin resistance. Despite some evidence in favor of
their use, the data could be confounded by the placebo
effect, suggesting that well-conducted, double-blind, ran-
domized, placebo-controlled studies are required for further
investigations. Further, C. I. Tsai et al. (“Chinese medicinal
formula (MHGWT) for relieving diabetic neuropathic pain:
a randomized, double-blind, placebo-controlled trial”) inves-
tigated the therapeutic effect of a modified TCM formula,
Hungqi Guizhi Wuwu Tang, on neuropathic pain in 112
diabetic patients, as assessed by 15-item short-form brief
pain inventory and the 17-item short-form McGill pain
questionnaire.This TCM significantly improved neuropathic
pain in the patients.
In addition to original research articles, this special issue
also features review articles. One review entitled “Herbal
therapies for type 2 diabetes mellitus: chemistry, biology,
and potential application of selected plants and compounds”
describes a variety of antidiabetic herbal products from
chemical, biological, pharmacological, and clinical aspects.
And another review entitled “Adjunctmethods of the standard
diabetic foot ulceration therapy” summarizes three adjunct
therapies, hyperbaric oxygen therapy, maggot therapy, and
platelet-rich plasma therapy in one of the most serious
diabetic complications, foot ulcers. The authors discuss pre-
clinical and clinical studies of those therapies together with
their effects and modes of action in animals and humans.
Both review articles shed light on further directions for CAM
in diabetes and diabetic complications.
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We envision that this special issue will attract broad
interest in the field of diabetes and encourage the perusal
of more in-depth investigations into the use of CAM-based
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